À propos
Consultant Clinical Oncologist – Prostate Cancer Specialist
Dr. Milan Anjanappa is a Consultant Clinical Oncologist specialising in the non-surgical treatment of prostate and complex urological cancers. He has over a decade of experience, having qualified as an Oncologist in 2015.
His aim is simple - to provide the highest standard of personalised cancer care while helping patients make confident, informed decisions about their treatment.
He has a busy NHS practice based at Mount Vernon Cancer Centre in London, one of the UK’s leading specialist cancer centres. He sees many complex cases and delivers advanced, personalised treatment using the latest radiotherapy and systemic therapies.
His private practice focuses on comprehensive care for men with prostate cancer, offering expert guidance and modern treatment options, including advanced radiotherapy techniques, hormone therapy, chemotherapy, immunotherapy, and targeted therapies, particularly for complex or challenging cases.
Dr. Anjanappa combines technical expertise
with a strong commitment to patient-centred care, ensuring each treatment plan
is tailored to the individual’s needs and priorities.
Advanced Prostate and Cancer Treatments
Dr Anjanappa specialises in the management of prostate cancer at all stages, from
newly diagnosed early disease through to advanced and recurrent cancer.
He has extensive expertise in state-of-the-art, non-surgical cancer treatments such as
radiotherapy and systemic treatments, including:
· Precision radiotherapy techniques (image-guided, stereotactic, MR-guided)
· Prostate brachytherapy (high-dose-rate and low-dose-rate seeds)
· Systemic therapies such as hormone therapy, chemotherapy,
immunotherapy, and targeted treatments
· Innovative therapies including Lu-PSMA radioligand therapy for advanced prostate cancer
Dr. Anjanappa’s approach allows treatments to be used alone or in combination, tailored to the patient’s individual needs.
He is particularly experienced in treating patients who:
Are exploring alternatives to surgery
· Have complex or recurrent prostate cancer
Require advanced radiotherapy techniques
· Are seeking highly individualised treatment planning or a second opinion
His expertise in advanced radiotherapy and targeted therapies ensures cancer is treated as effectively as possible while minimising side effects and preserving quality of life.
Dr Anjanappa is actively involved in clinical research aimed at improving outcomes
for patients with prostate cancer.
He has participated in numerous clinical trials and research studies as both Principal
Investigator and Sub-Investigator.
His research work includes involvement in major prostate cancer trials such as:
STAR-TRAP
POINTER-PC
STAMPEDE 2
These trials don’t just test new treatments; they inform the future standard of care.
The knowledge gained means more patients can receive safer, more effective, and personalised treatment, even if their cancer has returned or spread.
He has published in peer-reviewed medical journals and presented at national and international conferences.
Dr Anjanappa is recognised by colleagues and patients alike for his thoughtful,
thorough and compassionate care.
Patients value his willingness to spend time explaining complex medical information in a
clear and understandable way.
His combination of specialist expertise, advanced treatments and patient-centred
care makes him a trusted choice for men seeking expert treatment for prostate
cancer.
Dr. Milan Anjanappa is a Consultant Clinical Oncologist specialising in the non-surgical treatment of prostate and complex urological cancers. He has over a decade of experience, having qualified as an Oncologist in 2015.
His aim is simple - to provide the highest standard of personalised cancer care while helping patients make confident, informed decisions about their treatment.
He has a busy NHS practice based at Mount Vernon Cancer Centre in London, one of the UK’s leading specialist cancer centres. He sees many complex cases and delivers advanced, personalised treatment using the latest radiotherapy and systemic therapies.
His private practice focuses on comprehensive care for men with prostate cancer, offering expert guidance and modern treatment options, including advanced radiotherapy techniques, hormone therapy, chemotherapy, immunotherapy, and targeted therapies, particularly for complex or challenging cases.
Dr. Anjanappa combines technical expertise
with a strong commitment to patient-centred care, ensuring each treatment plan
is tailored to the individual’s needs and priorities.
Advanced Prostate and Cancer Treatments
Dr Anjanappa specialises in the management of prostate cancer at all stages, from
newly diagnosed early disease through to advanced and recurrent cancer.
He has extensive expertise in state-of-the-art, non-surgical cancer treatments such as
radiotherapy and systemic treatments, including:
· Precision radiotherapy techniques (image-guided, stereotactic, MR-guided)
· Prostate brachytherapy (high-dose-rate and low-dose-rate seeds)
· Systemic therapies such as hormone therapy, chemotherapy,
immunotherapy, and targeted treatments
· Innovative therapies including Lu-PSMA radioligand therapy for advanced prostate cancer
Dr. Anjanappa’s approach allows treatments to be used alone or in combination, tailored to the patient’s individual needs.
He is particularly experienced in treating patients who:
Are exploring alternatives to surgery
· Have complex or recurrent prostate cancer
Require advanced radiotherapy techniques
· Are seeking highly individualised treatment planning or a second opinion
His expertise in advanced radiotherapy and targeted therapies ensures cancer is treated as effectively as possible while minimising side effects and preserving quality of life.
Dr Anjanappa is actively involved in clinical research aimed at improving outcomes
for patients with prostate cancer.
He has participated in numerous clinical trials and research studies as both Principal
Investigator and Sub-Investigator.
His research work includes involvement in major prostate cancer trials such as:
STAR-TRAP
POINTER-PC
STAMPEDE 2
These trials don’t just test new treatments; they inform the future standard of care.
The knowledge gained means more patients can receive safer, more effective, and personalised treatment, even if their cancer has returned or spread.
He has published in peer-reviewed medical journals and presented at national and international conferences.
Dr Anjanappa is recognised by colleagues and patients alike for his thoughtful,
thorough and compassionate care.
Patients value his willingness to spend time explaining complex medical information in a
clear and understandable way.
His combination of specialist expertise, advanced treatments and patient-centred
care makes him a trusted choice for men seeking expert treatment for prostate
cancer.
“Evidence-based care tailored to each patient — taking the time to explain options and shared decisions.”
— Dr Milan Anjanappa
Formation et études
-
2011–2017 MD · Medicine and Surgery
-
2017–2021 Residency · Oncologie
Carrière et postes
-
2021-09–2022-08 Junior consultant
Licences et assurance
Licences médicales
GB — Organización Médica Colegial de España (OMC)
Certifications du conseil
European Board of Oncologie
Assurance responsabilité professionnelle :
Allianz Professional · 2,000,000 EUR couverture · No claims on file
Procédures réalisées
| Procédure | Code | Total à vie |
|---|---|---|
| GP consultation | 99213 | 2,868 |
| Annual physical exam | 99395 | 666 |
| Vaccination administration | 90471 | 2,010 |
| Minor procedure (skin) | 17110 | 869 |
Services et tarifs
| Service | Durée | Modalité | Prix |
|---|---|---|---|
| New patient consultation (60m) | 60 min | in_clinic|telemed | 180.00 EUR |
| Follow-up consultation (30m) | 30 min | in_clinic|telemed|phone | 90.00 EUR |
| Vaccination administration | 30 min | in_clinic | 360.00 EUR |
| Minor procedure (skin) | 120 min | in_clinic | 270.00 EUR |
Cabinet, équipe & en pratique
Vidéos
Recherche et publications
indice h : 20 · i10 : 9
-
Long-term follow-up of Oncologie across GB
DOI: 10.2299/euroclin.2026.0 · PMID: 33216555 · cité par 4
-
Validation of clinical scoring in Oncologie
DOI: 10.5916/euroclin.2025.1 · PMID: 38525189 · cité par 70
-
Long-term follow-up of Oncologie across GB
DOI: 10.9701/euroclin.2024.2 · PMID: 35878092 · cité par 176
Conférences invitées
- Practical updates in Oncologie European Annual Congress (Oncologie) · Vienna · 2024 · invited
- Single-centre experience in Oncologie National Society Meeting · Harpenden · 2023 · oral abstract
Récompenses et adhésions
Récompenses
- 🏆 Top-rated Oncologie — Harpenden · EuroClinics Patient Choice · 2025 · regional
- 🏆 Excellence in Patient Care · National Society · 2024 · national
- 🏆 Young Investigator Award · European Society · 2023 · international
Adhésions à des sociétés
- WONCA Europe — Family Doctors — Member · Depuis 2022
- national college of family doctors — Member · Depuis 2022
- European Union of Medical Specialists (UEMS) — Member · Depuis 2022
Articles de ce médecin
- Patient education Patient guide to Oncologie
- Awareness When should you see a oncologie?
Pour les patients internationaux
- Coordinateur
- Patient liaison · milan.anjanappa@euroclinics.example
- Assurances internationales acceptées
- Allianz Worldwide · AXA Global · BUPA Global · Cigna Global
Emplacement
1 baliseAvis des patients
56 avis vérifiés4.97
★★★★⯨
56 avis
- Bedside Manner
- 5.0
- Knowledge
- 5.0
- Wait Time
- 4.7
- Staff Friendliness
- 5.0
- Ease Of Appointment
- 4.9
- Value For Money
- 4.9
- Would Recommend Pct
- 98.0
Partagez votre expérience — aidez d'autres patients à trouver le bon médecin. Rédiger un avis →
Avis récents
-
★★★★★ ✓ Vérifié Very thorough first visit — explained every step. Booking was easy and the staff were welcoming.
-
★★★★★ ✓ Vérifié Took time to listen and reviewed all my previous results. I would absolutely recommend.
-
★★★★☆ ✓ Vérifié Professional and knowledgeable. Wait on the day was a bit long, otherwise excellent.
Spécialistes similaires
Tout parcourir →
Mr Abdulla Alhasso
Oncologie · Glasgow
Dr Alexander McDonald
Oncologie · Glasgow
Dr Amna Sheri
Oncologie · London
Dr Angus Robinson
Oncologie · Horley
Dr Anne Armstrong
Oncologie · Manchester
Dr Ashraf Azzabi
Oncologie · Washington
Dr Clare Green
Oncologie · Winchester
Dr Desmond Yip
Oncologie · Garran